Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Good afternoon, and thank you for joining ServiceNow's fourth quarter 2025 earnings conference call. Joining me are Bill McDermott, Chairman and Chief Executive Officer, Gina Mastantuono, our ...
Advsr AI Spotlight Highlighting notable AI moves at the intersection of strategic operating companies and emerging startups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results